Generex today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team, tomorrow, Thursday, January 4, 2018, at 10:30 a.m. Eastern time.
MIRAMAR, Fla.--(BUSINESS WIRE)-- Generex Biotechnology Corporation (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) (www.generex.com) today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team, tomorrow, Thursday, January 4, 2018, at 10:30 a.m. Eastern time:
| Toll Free: | 1-877-888-4291 | |||||||||||
| Passcode: | 35411 |
The purpose of the conference call is to provide Company stockholders and other interested parties with an update in respect of the Company’s initiatives and strategic plans.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180103005182/en/
Contacts
Generex Biotechnology Corporation
Joseph Moscato, 646-599-6222
or
Todd Falls, 800-391-6755, Extension 222
investor@generex.com
Source: Generex Biotechnology Corporation
View this news release online at:
http://www.businesswire.com/news/home/20180103005182/en
